These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7018710)

  • 1. [Pyrazidole in the treatment of endogenous depression: controlled study (author's transl)].
    Zapletálek M; Libiger J; Kaspárková E; Tůma I; Domkár J
    Cesk Psychiatr; 1981 Feb; 77(1):31-7. PubMed ID: 7018710
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the position of pyrazidol in the group of antidepressants in treatment of endogenous depression (author's transl)].
    Náhunek K; Svestka J; Rysánek R; Cesková E
    Cesk Psychiatr; 1981 Oct; 77(5):315-21. PubMed ID: 7326776
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP
    Psychopharmacol Bull; 1986; 22(1):186-91. PubMed ID: 3523576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with impavido in treatment of endogenous depressive conditions (author's transl)].
    Náhunek K; Cesková E; Svestka J
    Cesk Psychiatr; 1977 Aug; 73(4):226-33. PubMed ID: 336226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)].
    Zapletálek M; Zbytovský J; Libiger J; Pazdírek S; Cápová E
    Cesk Psychiatr; 1981 Jun; 77(3):198-203. PubMed ID: 6119162
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effectiveness of mianserin and pyrazidol in endogenous depression].
    Mosolov SN; Sharov AI; Kogan AD; Ryvkin PV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):108-14. PubMed ID: 2167573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. II. Comparison of the effects of various thymoleptics on the psychopathological symptoms of endogenous depressive syndromes].
    Strzyzewski W; Twarowska-Hauser J; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
    Psychiatr Pol; 1985; 19(5):363-9. PubMed ID: 3913976
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. III. Analysis of the factors affecting the effectiveness of treatment with thymoleptics].
    Twarowska-Hauser J; Strzyzewski W
    Psychiatr Pol; 1985; 19(5):370-5. PubMed ID: 3913977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles].
    Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
    Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of controlled studies comparing mianserin and clomipramine (author's transl)].
    de Buck RP
    Encephale; 1981; 7(4 Suppl):455-72. PubMed ID: 7032887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panic attacks in outpatients with depression: response to antidepressant treatment.
    Robinson DS; Kayser A; Corcella J; Laux D; Yingling K; Howard D
    Psychopharmacol Bull; 1985; 21(3):562-7. PubMed ID: 3898179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of the seasons on the course and therapeutic results of depressive phases of maniomelancholy (author's transl)].
    Sedivec V
    Cesk Psychiatr; 1981 Oct; 77(5):326-30. PubMed ID: 7326778
    [No Abstract]   [Full Text] [Related]  

  • 17. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 18. Is loss of antidepressant effect during continuation therapy related to placebo effect?
    Harrison W; Stewart JW; McGrath PJ; Tricamo E; Quitkin FM
    Psychopharmacol Bull; 1988; 24(1):9-13. PubMed ID: 3290953
    [No Abstract]   [Full Text] [Related]  

  • 19. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
    Zhang ZJ; Tan QR; Tong Y; Li Q; Kang WH; Zhen XC; Post RM
    J Affect Disord; 2008 Jul; 109(1-2):91-7. PubMed ID: 18093662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.